Insiders Provectus Biopharmaceuticals, Inc.

Equities

PVCT

US74373P1084

Delayed OTC Markets Other stock markets 10:35:03 10/05/2024 pm IST			5-day change	1st Jan Change
0.1921 ^USD	-1.94%		-0.52%	+100.10%

18/04	Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose	CI
16/04	Provectus Biopharmaceuticals, Inc. Appoints Dominic Rodrigues as President	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Provectus Biopharmaceuticals, Inc. Appoints Dominic Rodrigues as President	16/04	CI
Provectus Biopharmaceuticals, Inc. Appoints Ed Pershing as Chief Executive Officer	16/04	CI
Provectus Biopharmaceuticals, Inc. Announces Management Changes	27/03	CI
Provectus Biopharmaceuticals Names Aru Narendran, MD, PhD to Scientific Advisory Board	14/22/14	CI
Provectus Biopharmaceuticals, Inc. Announces Board Changes	16/20/16	CI
Provectus Biopharmaceuticals Inc. Names Harold Schmitz to Scientific Advisory Board	11/19/11	CI
Provectus Names Frank Akers to Company’S Strategic Advisory Board	29/19/29	CI
Provectus Biopharmaceuticals, Inc. Appoints Bruce Horowitz as Chief Operating Officer	09/19/09	CI
Provectus Biopharmaceuticals, Inc. Announces Changes to the Company’s Board of Directors, Effective April 27, 2018	24/18/24	CI
Provectus Biopharmaceuticals, Inc. Reestablishes Strategic Advisory Board	21/17/21	CI
Provectus Biopharmaceuticals Closes Definitive Financing with PRH Group; Announces Management Changes	04/17/04	CI
Provectus Biopharmaceuticals, Inc. Announces Board Changes	04/17/04	CI
Provectus Biopharmaceuticals, Inc. Announces Financing Up to $20 Million; Announces Board Changes	30/17/30	CI
Peter R. Culpepper Nominates Candidates to the Board of Provectus Biopharmaceuticals	27/17/27	CI
Provectus Biopharmaceuticals Terminates Peter R. Culpepper as Interim CEO and COO	29/16/29	CI
Provectus Biopharmaceuticals, Inc. Appoints John R. Glass as Interim Chief Financial Officer	22/16/22	CI
Provectus Biopharmaceuticals, Inc. Announces Management Changes	29/16/29	CI
Provectus Biopharmaceuticals Appoints Christopher Kaplan to its Strategic Advisory Board	22/14/22	CI
Provectus Biopharmaceuticals Inc. Appoints Jacob M. Plotsker to Strategic Advisory Board	21/14/21	CI
Provectus Biopharmaceuticals Inc. Appoints Brendan O'Brien to Strategic Advisory Board	06/14/06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Provectus Biopharmaceuticals, Inc.

Equities

PVCT

US74373P1084

Insiders

Filters